Cargando…

The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants

BACKGROUND: The human malaria parasite Plasmodium vivax infects red blood cells through a key pathway that requires interaction between Duffy binding protein II (DBPII) and its receptor on reticulocytes, the Duffy antigen/receptor for chemokines (DARC). A high proportion of P. vivax-exposed individu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kano, Flora S., Souza-Silva, Flávia A., Torres, Leticia M., Lima, Barbara A. S., Sousa, Taís N., Alves, Jéssica R. S., Rocha, Roberto S., Fontes, Cor J. F., Sanchez, Bruno A. M., Adams, John H., Brito, Cristiana F. A., Pires, Douglas E. V., Ascher, David B., Sell, Ana Maria, Carvalho, Luzia H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154503/ https://www.ncbi.nlm.nih.gov/pubmed/27959918 http://dx.doi.org/10.1371/journal.pntd.0005177

Ejemplares similares

Distinct HLA class II alleles influence antibody response to the Plasmodium vivax Duffy binding protein
por: Kano, Flora S, et al.
Publicado: (2014)

Duffy Antigen Receptor for Chemokine (DARC) Polymorphisms and Its Involvement in Acquisition of Inhibitory Anti-Duffy Binding Protein II (DBPII) Immunity
por: Souza-Silva, Flávia A., et al.
Publicado: (2014)

Plasmodium vivax infection: atypical memory B cells are expanded and associated with the persistence of Duffy binding protein II (DBPII) antibody response
por: Kano, Flora S, et al.
Publicado: (2014)

The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon
por: de Sousa, Taís Nóbrega, et al.
Publicado: (2014)

Plasmodium simium, a Plasmodium vivax-Related Malaria Parasite: Genetic Variability of Duffy Binding Protein II and the Duffy Antigen/Receptor for Chemokines
por: Camargos Costa, Daniela, et al.
Publicado: (2015)

Susceptibility to Plasmodium vivax malaria associated with DARC (Duffy antigen) polymorphisms is influenced by the time of exposure to malaria
por: Kano, Flora Satiko, et al.
Publicado: (2018)

Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development
por: Nóbrega de Sousa, Taís, et al.
Publicado: (2011)

Genetic variability and natural selection at the ligand domain of the Duffy binding protein in brazilian Plasmodium vivax populations
por: Sousa, Taís N, et al.
Publicado: (2010)

Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period
por: Medeiros, Camila M. P., et al.
Publicado: (2020)

Multiplexed Microsphere-Based Flow Cytometric Assay to Assess Strain Transcending Antibodies to Plasmodium vivax Duffy Binding Protein II Reveals an Efficient Tool to Identify Binding-Inhibitory Antibody Responders
por: Alves, Jéssica R. S., et al.
Publicado: (2021)

An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
por: Ntumngia, Francis B., et al.
Publicado: (2017)

Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology
por: de Souza, Aracele M., et al.
Publicado: (2015)

Genetic variability of Plasmodium vivax from primary–relapses paired samples
por: Araujo, Flávia C, et al.
Publicado: (2012)

Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses
por: Silvino, Ana Carolina Rios, et al.
Publicado: (2016)

Correction: Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses
por: Silvino, Ana Carolina Rios, et al.
Publicado: (2018)

Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region
por: Pires, Camilla V., et al.
Publicado: (2018)

A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy-Positive Reticulocytes
por: Ntumngia, Francis B., et al.
Publicado: (2016)

Multiple-Clone Activation of Hypnozoites Is the Leading Cause of Relapse in Plasmodium vivax Infection
por: de Araujo, Flávia Carolina F., et al.
Publicado: (2012)

Augmented plasma microparticles during acute Plasmodium vivax infection
por: Campos, Fernanda MF, et al.
Publicado: (2010)

Characterization of Duffy Binding Protein II-specific CD4(+)T cell responses in Plasmodium vivax patients
por: Thawornpan, Pongsakorn, et al.
Publicado: (2023)

Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response
por: Dias, Michelle H. F., et al.
Publicado: (2022)

Plasmodium vivax Infection in Duffy-Negative People in Africa
por: Zimmerman, Peter A.
Publicado: (2017)

Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax
por: de Cassan, Simone C., et al.
Publicado: (2015)

Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature
por: Costa, Gabriel Luíz, et al.
Publicado: (2017)

Characterization of Inhibitory Anti-Duffy Binding Protein II Immunity: Approach to Plasmodium vivax Vaccine Development in Thailand
por: Chootong, Patchanee, et al.
Publicado: (2012)

Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia
por: Lo, Eugenia, et al.
Publicado: (2015)

Is the single variant form of Plasmodium vivax Duffy binding protein-II (PvDBP-II) adequate for inclusion in a PvDBP-II-based vaccine?
por: Valizadeh, Vahideh, et al.
Publicado: (2014)

Distribution of Duffy Phenotypes among Plasmodium vivax Infections in Sudan
por: Albsheer, Musab M.A., et al.
Publicado: (2019)

Reduced Plasmodium vivax Erythrocyte Infection in PNG Duffy-Negative Heterozygotes
por: Kasehagen, Laurin J., et al.
Publicado: (2007)

Plasmodium vivax infection in Anajás, State of Pará: no differential resistance profile among Duffy-negative and Duffy-positive individuals
por: Carvalho, Tarcisio AA, et al.
Publicado: (2012)

Plasma Circulating Nucleic Acids Levels Increase According to the Morbidity of Plasmodium vivax Malaria
por: Franklin, Bernardo S., et al.
Publicado: (2011)

Plasmodium vivax Duffy binding protein: understanding targets of protective immunity
por: Adams, John H, et al.
Publicado: (2014)

Duffy Phenotype and Plasmodium vivax infections in Humans and Apes, Africa
por: Culleton, Richard Leighton, et al.
Publicado: (2012)

The Interface Between Inflammatory Mediators and MicroRNAs in Plasmodium vivax Severe Thrombocytopenia
por: Santos, Marina L. S., et al.
Publicado: (2021)

High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana
por: Brown, Charles A., et al.
Publicado: (2021)

Frequent expansion of Plasmodium vivax Duffy Binding Protein in Ethiopia and its epidemiological significance
por: Lo, Eugenia, et al.
Publicado: (2019)

Cross-reactive inhibitory antibody and memory B cell responses to variant strains of Duffy binding protein II at post-Plasmodium vivax infection
por: Thawornpan, Pongsakorn, et al.
Publicado: (2022)

Asymptomatic Plasmodium vivax infections among Duffy-negative population in Kedougou, Senegal
por: Niang, Makhtar, et al.
Publicado: (2018)

Prevalence and distribution of Plasmodium vivax Duffy Binding Protein gene duplications in Sudan
por: Ahmed, Safaa, et al.
Publicado: (2023)

Vivax malaria in Mauritania includes infection of a Duffy-negative individual
por: Wurtz, Nathalie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u54ftrds0evds7jifnace3ub00